P-63 MATTERHORN: A phase 3 study of efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer
Title:
P-63 MATTERHORN: A phase 3 study of efficacy and safety of neoadjuvant-adjuvant durvalumab and FLOT chemotherapy in resectable gastric and gastroesophageal junction cancer
Author:
Janjigian, Y. Van Cutsem, E. Muro, K. Wainberg, Z. Al-Batran, S. Hyung, W. Molena, D. Evans, B. Ruscica, D. Robbins, S. Negro, A. Tabernero, J.